4 Important Questions To Ask Before A Clinical Trial

Posted on: 24 January 2022

If you are considering participation in a clinical trial for Parkinson's disease, you probably have a lot of questions. Clinical trials have a lot of benefits, but it is important that you understand how they work before you make a decision about your participation.

Are you considering Parkinson's disease clinical trials, here's what you should know first.

What Are the Phases of a Clinical Trial?

A clinical trial begins in Phase I. During this stage, researchers are just beginning to test a new treatment. A few people are selected to participate while the researchers evaluate the treatment option to determine possible side effects and a safe dose for use. Then, the trial moves into Phase II when more people will try the treatment.

If all continues to go well, the clinical trial will move into Phase III, which involves an even larger group of people. This will provide insight into the effectiveness and benefits of the treatment option before Stage IV, which occurs when the FDA approves the drug. This phase allows for further research into the treatment post-approval.

What Are the Benefits of a Clinical Trial?

When you join a clinical trial, there is a good chance you will be working with healthcare professionals who are at the top of their field. They are dedicated to providing quality care, and they understand your needs on a level other providers may not.

Signing up for a clinical trial also allows you to have an additional understanding of Parkinson's disease. You will develop knowledge about your condition that you would not have had otherwise. Finally, this trial could help lead to true advancements in the field. Your role could help others get treatment for Parkinson's in the future.

What Are the Risks of a Clinical Trial?

Any type of medical treatment can have some risks, and there is always the chance that a clinical trial can have some side effects. By the time clinical trials are underway, the process should be safe enough. Still, it is important to be aware of the possible consequences.

Additionally, there is the chance that you might not get effective treatment. Your particular Parkinson's disease may not be treated based on a number of important factors.

Should You Join a Clinical Trial?

This is a decision only you can make. If you choose to join a trial, it is important that you do so under the guidance of a medical professional and with complete understanding of the process. For more information on early stage Parkinson's clinical trials, speak with your doctor or a clinical trial provider, such as Institute for Neurodegenerative Disorders.